The Horseracing Integrity and Safety Authority (HISA) announced the suspension of negotiations pertaining to USADA's potential future role as the independent enforcement agency for HISA's Anti-Doping and Medication Control (ADMC) program. As mandated by the Horseracing Integrity and Safety Act of 2020, USADA and HISA had been engaged in good faith negotiations but were unable to reach final terms. To date, USADA has led the process of authoring draft rules for HISA's ADMC program. As set forth in the HISA statute, the Authority is evaluating options for engagement with other leading independent enforcement agencies.
The draft Racetrack Safety regulations that were submitted to the FTC earlier this month will be implemented as scheduled by the FTC on July 1, 2022, following review, public comment and education periods. There will be a temporary delay in submission of the Anti-Doping and Medication Control draft rules to the FTC until a new independent agency can be identified and an agreement finalized. This will allow HISA and another independent enforcement agency to reach an agreement and build on the progress that has been made to-date with USADA. HISA anticipates this process will permit the full implementation of the final ADMC rules in early 2023.
“We are deeply grateful for USADA's hard work, expertise and leadership in working with HISA's Anti-Doping and Medication Committee to develop comprehensive draft rules in a remarkably short period of time,” said HISA Board Chair Charles Scheeler. “HISA will continue our search for an independent enforcement agency to oversee the Medication Control protocols. The Authority will also work with the FTC to ensure the Racetrack Safety Program advances on schedule. When operational, the program will provide critical enhancements to protect the health and safety of equine and human athletes.”
The post Unable To Reach Final Terms: Horseracing Integrity And Safety Authority Suspends Negotiations With USADA appeared first on Horse Racing News | Paulick Report.
